207 related articles for article (PubMed ID: 11560062)
1. Structure-based virtual screening protocols.
Good A
Curr Opin Drug Discov Devel; 2001 May; 4(3):301-7. PubMed ID: 11560062
[TBL] [Abstract][Full Text] [Related]
2. Analysis and optimization of structure-based virtual screening protocols (1): exploration of ligand conformational sampling techniques.
Good AC; Cheney DL
J Mol Graph Model; 2003 Sep; 22(1):23-30. PubMed ID: 12798388
[TBL] [Abstract][Full Text] [Related]
3. Towards improving compound selection in structure-based virtual screening.
Waszkowycz B
Drug Discov Today; 2008 Mar; 13(5-6):219-26. PubMed ID: 18342797
[TBL] [Abstract][Full Text] [Related]
4. Analysis and optimization of structure-based virtual screening protocols. (3). New methods and old problems in scoring function design.
Smith R; Hubbard RE; Gschwend DA; Leach AR; Good AC
J Mol Graph Model; 2003 Sep; 22(1):41-53. PubMed ID: 12798390
[TBL] [Abstract][Full Text] [Related]
5. The use of protein-ligand interaction fingerprints in docking.
Brewerton SC
Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
[TBL] [Abstract][Full Text] [Related]
6. Novel technologies for virtual screening.
Lengauer T; Lemmen C; Rarey M; Zimmermann M
Drug Discov Today; 2004 Jan; 9(1):27-34. PubMed ID: 14761803
[TBL] [Abstract][Full Text] [Related]
7. Efficient virtual screening using multiple protein conformations described as negative images of the ligand-binding site.
Virtanen SI; Pentikäinen OT
J Chem Inf Model; 2010 Jun; 50(6):1005-11. PubMed ID: 20504004
[TBL] [Abstract][Full Text] [Related]
8. Considerations in compound database preparation--"hidden" impact on virtual screening results.
Knox AJ; Meegan MJ; Carta G; Lloyd DG
J Chem Inf Model; 2005; 45(6):1908-19. PubMed ID: 16309298
[TBL] [Abstract][Full Text] [Related]
9. Analysis and optimization of structure-based virtual screening protocols. 2. Examination of docked ligand orientation sampling methodology: mapping a pharmacophore for success.
Good AC; Cheney DL; Sitkoff DF; Tokarski JS; Stouch TR; Bassolino DA; Krystek SR; Li Y; Mason JS; Perkins TD
J Mol Graph Model; 2003 Sep; 22(1):31-40. PubMed ID: 12798389
[TBL] [Abstract][Full Text] [Related]
10. Ranking targets in structure-based virtual screening of three-dimensional protein libraries: methods and problems.
Kellenberger E; Foata N; Rognan D
J Chem Inf Model; 2008 May; 48(5):1014-25. PubMed ID: 18412328
[TBL] [Abstract][Full Text] [Related]
11. Ligand-target interaction-based weighting of substructures for virtual screening.
Crisman TJ; Sisay MT; Bajorath J
J Chem Inf Model; 2008 Oct; 48(10):1955-64. PubMed ID: 18821751
[TBL] [Abstract][Full Text] [Related]
12. Beyond the virtual screening paradigm: structure-based searching for new lead compounds.
Schlosser J; Rarey M
J Chem Inf Model; 2009 Apr; 49(4):800-9. PubMed ID: 19354328
[TBL] [Abstract][Full Text] [Related]
13. Novel 2D fingerprints for ligand-based virtual screening.
Ewing T; Baber JC; Feher M
J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
[TBL] [Abstract][Full Text] [Related]
14. Lead optimization via high-throughput molecular docking.
Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
[TBL] [Abstract][Full Text] [Related]
15. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.
Tanrikulu Y; Schneider G
Nat Rev Drug Discov; 2008 Aug; 7(8):667-77. PubMed ID: 18636071
[TBL] [Abstract][Full Text] [Related]
16. Virtual screening strategies in drug discovery.
McInnes C
Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
[TBL] [Abstract][Full Text] [Related]
17. Virtual screening in lead discovery and optimization.
Jain AN
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):396-403. PubMed ID: 15338948
[TBL] [Abstract][Full Text] [Related]
18. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
Mizutani MY; Itai A
J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening.
Pérez-Nueno VI; Pettersson S; Ritchie DW; Borrell JI; Teixidó J
J Chem Inf Model; 2009 Apr; 49(4):810-23. PubMed ID: 19358515
[TBL] [Abstract][Full Text] [Related]
20. Virtual high-throughput screening of molecular databases.
Seifert MH; Kraus J; Kramer B
Curr Opin Drug Discov Devel; 2007 May; 10(3):298-307. PubMed ID: 17554856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]